Return on Equity (ROE)
Updated 654h ago
Sector Performance
51th percentileEFX
14.4%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how effectively a company generates profit from shareholders’ money—a 14.4% ROE means EFX earns about 14.4 cents of profit for every dollar of equity.
This sits slightly above the sector median of 13.5%, placing EFX in the 53rd percentile of its peer group, a middling position. Trend data is not available: the year-over-year change and quarter-over-quarter change are both marked N/A, and no historical values beyond the current figure were provided. With a moderate ROE level that is only marginally above the peer median and no trend to indicate improvement or deterioration, the risk-return profile appears balanced. The absence of a trend means there is no signal of momentum, so the metric does not push toward a bullish or bearish view. This stable, average-level ROE aligns with the overall NEUTRAL verdict, neither confirming nor contradicting it.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about EFX?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are EFX's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master EFX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full EFX research report →EFX
14.4%
Sector Median
13.8%
Sector Avg
31.4%
How EFX's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.